Skip to main content

Statistical analysis of the adverse effects of glycopeptide antibiotics, based on pharmacokinetics and toxicokinetics (PK/TK)

Abstract

The effects of vancomycin hydrochloride (VCM) and teicoplanin complex (TEIC) on hepatic function and renal function were evaluated in rats. VCM was injected via the jugular vein at doses of 40, 100, and 250 mg/kg, and TEIC was injected via the jugular vein at doses of 10, 30, 40, 50, and 60 mg/kg, both after being dissolved in 1 ml of saline solution. Increased doses of VCM significantly increased the integrated plasma concentrations, from 0 to 8 h, for blood urea nitrogen (BUN0–8) and serum creatinine (SCr0–8). TEIC gave rise to a slight increase in both BUN0–8 and SCr0–8 as its dose was increased. On the other hand, TEIC significantly increased the integrated plasma concentrations, from 0 to 8 h, for aspartate aminotransferase (AST0–8), and alanine aminotransferase (ALT0–8), at doses from 40 mg/kg to 60 mg/kg, though VCM did not increase these concentrations. This study suggests the importance of paying attention to hepatic function – in addition to renal function – when TEIC is administered to patients with methicillin-resistant Staphylococcus aureus (MRSA).

This is a preview of subscription content, access via your institution.

References

  1. M Doteuchi H Satoh K Otani K Koyabe Y Inoue M Horiuchi et al. (1992) ArticleTitleGeneral pharmacological actions of vancomycin Oyo Yakuri/Pharmacometrics 43 587–602 Occurrence Handle1:CAS:528:DyaK38XkvVaqt7g%3D

    CAS  Google Scholar 

  2. B Fauconneau C Pariat S Bouquet A Piriou P Ingrand P Courtois (1993) ArticleTitleA comparative study of enzymuria, in the rat, of the drug combinations amikacin/vancomycin and amikacin/ teicoplanin Ren Fail 15 469–73 Occurrence Handle8105516 Occurrence Handle1:CAS:528:DyaK3sXksVSgs7Y%3D

    PubMed  CAS  Google Scholar 

  3. RD Pryka KA Rodvold JC Rotschafer (1988) ArticleTitleTeicoplanin: an investigational glycopeptide antibiotic Clin Pharm 7 647–58 Occurrence Handle2977108 Occurrence Handle1:CAS:528:DyaL1cXls1akurs%3D

    PubMed  CAS  Google Scholar 

  4. AP Wilson (2000) ArticleTitleClinical pharmacokinetics of teicoplanin Clin Pharmacokinet 39 167–83 Occurrence Handle11020133 Occurrence Handle1:STN:280:DC%2BD3cvmsV2lsg%3D%3D Occurrence Handle10.2165/00003088-200039030-00001

    PubMed  CAS  Article  Google Scholar 

  5. GR Matzke GG Zhanel DR Guay (1986) ArticleTitleClinical pharmacokinetics of vancomycin Clin Pharmacokinet 11 257–82 Occurrence Handle3530582 Occurrence Handle1:CAS:528:DyaL28XlsVGmsr0%3D Occurrence Handle10.2165/00003088-198611040-00001

    PubMed  CAS  Article  Google Scholar 

  6. K Ueno H Hashimoto M Ikura H Yoshimura K Mitsutake (2003) ArticleTitleEvaluation of pharmacokinetics and effects of teicoplanin in treating patients with MRSA infection Jpn J Chemother 51 168–72 Occurrence Handle1:CAS:528:DC%2BD3sXjsFagt7w%3D

    CAS  Google Scholar 

  7. T Hayakawa H Kishimoto A Takino H Nakayama T Monden N Shibata et al. (2001) ArticleTitleAppropriateness of MRSA infection remedy based on therapeutic drug monitoring of teicoplanin TDM Kenkyu 18 179–80

    Google Scholar 

  8. RA Upton (1975) ArticleTitleSimple and reliable method for serial sampling of blood from rats J Pharm Sci 64 112–4 Occurrence Handle1133682 Occurrence Handle1:CAS:528:DyaE2MXhs1Cls7k%3D

    PubMed  CAS  Google Scholar 

  9. K Yamaoka Y Tanigawara T Nakagawa T Uno (1981) ArticleTitleA pharmacokinetic analysis program (MULTI) for microcomputer J Pharmacobiodyn 4 879–85 Occurrence Handle7328489 Occurrence Handle1:CAS:528:DyaL38XksFyntg%3D%3D

    PubMed  CAS  Google Scholar 

  10. JS Wold SA Turnipseed (1981) ArticleTitleToxicology of vancomycin in laboratory animals Rev Infect Dis 3 S224–9 Occurrence Handle7342285

    PubMed  Google Scholar 

  11. MJ Wood (1996) ArticleTitleThe comparative efficacy and safety of teicoplanin and vancomycin J Antimicrob Chemother 37 209–22 Occurrence Handle8707731 Occurrence Handle1:CAS:528:DyaK28XhsVCgs70%3D

    PubMed  CAS  Google Scholar 

  12. AP Wilson (1998) ArticleTitleComparative safety of teicoplanin and vancomycin Int J Antimicrob Agents 10 143–52 Occurrence Handle9716291 Occurrence Handle1:CAS:528:DyaK1cXltFylt70%3D Occurrence Handle10.1016/S0924-8579(98)00025-9

    PubMed  CAS  Article  Google Scholar 

  13. MJ Wood (2000) ArticleTitleComparative safety of teicoplanin and vancomycin J Chemother 12 21–5 Occurrence Handle11131960

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kenji Matsuyama.

About this article

Cite this article

Yoshida, M., Matzno, S., Namba, H. et al. Statistical analysis of the adverse effects of glycopeptide antibiotics, based on pharmacokinetics and toxicokinetics (PK/TK). J Infect Chemother 12, 114–118 (2006). https://doi.org/10.1007/s10156-006-0437-z

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10156-006-0437-z

Key words

  • Vancomycin
  • Teicoplanin
  • Renal dysfunction
  • hepatic dysfunction